Search

Search results

335 results found

In Vitro Target Validation

Target validation of agents or combinations of agents in cell culture in one or more murine and human tumor cell lines or mouse embryonic fibroblasts (MEFs) of various genotypes (see below). Use of several different assays depending upon the agent and type of information sought. Availability of an...

Sarnoff Fellow Daniel Johnson Presents at 2025 Sarnoff Conference

Daniel Johnson, BA presented one of his year-long research projects this weekend at the 2025 Sarnoff Cardiovascular Research Foundation Annual Scientific Meeting in Cambridge, MA. Daniel is a fourth-year medical student at the University of Chicago Pritzker School of Medicine who has joined the...

Interviews

March 2025 - Endocrine News interview (PDF) March 2025 - Women's Interprofessional Network of the American Diabetes Association (WIN ADA) interview (video) March 2020 - The Journal of Clinical Investigation (JCI), Conversations with Giants in Medicine: Barbara Kahn (video and PDF) Aug 2016 - Cell...

India 2047: Building a Climate-Resilient Future

India 2047 was co-hosted by  The Lakshmi Mittal and Family South Asia Institute and the  Salata Institute for Climate and Sustainability at Harvard University  in collaboration with the  Ministry of Environment, Forest and Climate Change, Government of India. Led by Program Director Dr Satchit...

Faculty and Mentees have Strong Showing at SCAI 2025

Four mentees took the stage at SCAI 2025, presenting on topics including: trends and outcomes of PCIs performed in ambulatory surgical centers ( Katerina Dangas), differences in PCI follow-up care for black vs. white patients ( Frank Medina), outcomes of CLTI among Medicare beneficiaries ( Maxime...

Impact

The work of the Interventional Cardiology and Vascular Research section has had important implications for cardiovascular device regulation. Our section has been deeply involved in regulatory science, in particular the generation of timely safety data for post-market device evaluation. Our group has...